Trial Profile
Clinical Trials Insight: 700026558
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 29 Aug 2007
Price :
$35
*
At a glance
- Drugs KOS 2187 (Primary)
- Indications Gastro-oesophageal reflux
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 29 Aug 2007 New trial record.